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Transcription controls splicing and other gene regu-
latory processes, yet mechanisms remain obscure
due to our fragmented knowledge of the molecular
connections between the dynamically phosphory-
lated RNA polymerase II (Pol II) C-terminal domain
(CTD) and regulatory factors. By systematically
isolating phosphorylation states of the CTD hepta-
peptide repeat (Y1S2P3T4S5P6S7), we identify hun-
dreds of protein factors that are differentially
enriched, revealing unappreciated connections be-
tween the Pol II CTD and co-transcriptional pro-
cesses. These data uncover a role for threonine-4 in
30 end processing through control of the transition
between cleavage and termination. Furthermore,
serine-5 phosphorylation seeds spliceosomal as-
sembly immediately downstream of 30 splice sites
through a direct interaction with spliceosomal sub-
complex U1. Strikingly, threonine-4 phosphorylation
also impacts splicing by serving as amark of co-tran-
scriptional spliceosome release and ensuring effi-
cient post-transcriptional splicing genome-wide.
Thus, comprehensive Pol II interactomes identify
the complex and functional connections between
transcription machinery and other gene regulatory
complexes.INTRODUCTION
Transcription regulation controls both RNA transcript levels and
the final sequence of the RNA transcript through regulated coor-
dination with co-transcriptional RNA processing. Capping,
splicing, and termination are coupled to transcription through
phosphorylation of the C-terminal domain (CTD) of the largest
RNA polymerase II (Pol II) subunit. The CTD extends from the
Pol II body and consists of a conserved heptapeptide, Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, repeated 26 times in yeast
and 52 times in humans. Five of the seven residues are dynam-Ce
This is an open access article under the CC BY-Nically phosphorylated during the transcription cycle in a
characteristic pattern across gene bodies. (Fuchs et al., 2009;
Hintermair et al., 2012; Jeronimo et al., 2013; Komarnitsky
et al., 2000; Mayer et al., 2010, 2012). Phosphorylation of partic-
ular CTD residues contributes to the recruitment of key regula-
tory factors at the right place and time, facilitating connections
to co-transcriptional processes. Yet, the extent of connections
between CTD phosphorylation marks and RNA-processing
machinery are not clear. A focus on identifying direct phospho-
CTD binding proteins has slowed experimental throughput and
overlooked mechanisms that occur through phosphorylation
marks blocking regulatory interactions or indirectly connecting
transcription to other processes.
The best-characterized CTD residues are Ser2 and Ser5. Pol II
complexes containing high levels of phospho-Ser2 (Ser2P) are
thought to be involved in the latter stages of transcription as
Ser2P rises slowly across gene bodies and peaks at the
30 ends of genes (Barilla` et al., 2001; Kim et al., 2004). A termina-
tion factor, Rtt103, directly binds Ser2P, yet is only recruited after
the polyadenylation (polyA) site. This specificity is controlled in
part by phospho-Tyr1 (Tyr1P), presumably through blocking
Rtt103 binding before the polyA site (Mayer et al., 2012). It is un-
clear whether additional residues contribute to the precise
recruitment of Rtt103 and, more generally, howmultiple residues
might work together in the coupling of other RNA-processing
events to transcription.
Pol II complexes containing high levels of phospho-Ser5
(Ser5P) are enriched near the transcription start site (TSS) of
genes, consistent with the essential role of Ser5P in the earliest
mRNA-processing event, capping of the nascent RNA (Cho
et al., 1997; Komarnitsky et al., 2000; McCracken et al., 1997;
Schroeder et al., 2000; Schwer and Shuman, 2011). Recently,
a connection between Ser5P and splicing has been suggested.
In yeast, Ser5P increases transiently during a splicing-related
transcription checkpoint at the 30 splice site, where Pol II pauses
and does not resume transcription until splicing-related events
occur (Alexander et al., 2010; Chathoth et al., 2014). However
it remains unclear whether there are direct connections between
splicing and Ser5P or the CTD in general (Licatalosi et al., 2002).
Initial studies indicated a component of the spliceosome (Prp40)
could directly bind the CTD (Morris and Greenleaf, 2000). How-
ever, other work showed no defect on the co-transcriptionalll Reports 15, 2147–2158, June 7, 2016 ª 2016 The Authors. 2147
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
recruitment of the spliceosome in strains where the CTD-binding
domain of Prp40 was removed (Go¨rnemann et al., 2011). Thus,
despite the observation of co-transcriptional splicing and spli-
ceosomal assembly (Bentley, 2014; Kotovic et al., 2003; Lacadie
and Rosbash, 2005; Lacadie et al., 2006; Moore et al., 2006; Tar-
diff et al., 2006), the degree of coupling between the transcription
and splicingmachineries, andwhat role Ser5Pmay play, remains
unclear.
Not all CTD residues are as well characterized as Ser2 and
Ser5. For example, Thr4 regulates elongation in human cells,
but phospho-Thr4 (Thr4P) levels peak after polyA sites (Hinter-
mair et al., 2012). Substitution of valine for each CTD threonine
yielded a defect only in 30 end processing of histone mRNAs in
chicken DT40 cells (Hsin et al., 2011) and had minimal impact
on the transcriptome in yeast (Rosonina et al., 2014). Yet, recent
mass spectrometry analysis of the Pol II CTD showed that Thr4P
is possibly as abundant as Ser2P, suggesting that key roles for
this residue remain to be discovered (Sch€uller et al., 2016).
To determine unappreciated connections between CTD phos-
phorylation and RNAprocessing, we performed an unbiased and
comprehensive analysis of phospho-specific Pol II complexes.
We developed a sequential purification strategy to purify Pol II
complexes enriched for each CTD phosphoisoform and used
quantitative label-free mass spectrometry to identify factors
that interact with phospho-specific Pol II complexes compared
to all Pol II complexes. Application of this approach to Saccharo-
myces cerevisiae identified unique phospho-specific Pol II inter-
actomes for the five phosphorylatable CTD residues. The factors
enriched in each phospho-CTD interactome allow prediction and
discovery of new roles for individual factors and phospho-CTD
residues. By combining the interactome data with multiple
high-resolution genomic techniques, we describe a previously
uncharacterized role for Thr4 in transcription termination in
yeast, through the recruitment of termination factors and regula-
tion of Pol II dynamics.
Our proteomic analysis reveals a striking differential enrich-
ment of the spliceosome as a function of CTD phosphorylation.
The Ser5P interactome is strongly enriched with U1 spliceoso-
mal components, and we demonstrate that Ser5P contributes
directly to the co-transcriptional recruitment of the spliceosome.
The Thr4P interactome has a complete lack of enriched spliceo-
some subunits, and we observe that this mark peaks in the
terminal exon after dissociation of splicing machinery. Thr4 is
required in the post-transcriptional completion of splicing,
demonstrating that CTDmodifications impact both co-transcrip-
tional and post-transcriptional splicing through separate resi-
dues. Together, these data comprehensively define the protein
factors that associate with Pol II and uncover roles for CTDmod-
ifications in splicing and termination regulation.
RESULTS
Proteomic Analysis of Phospho-specific Pol II
Complexes
To determine the compendium of factors that associate to
actively transcribing Pol II, we first analyzed purifications of
total Pol II by label-free quantitative mass spectrometry. We
adapted the immunoprecipitation approach developed for native2148 Cell Reports 15, 2147–2158, June 7, 2016elongating transcript sequencing (NET-seq), whereby engaged
Pol II complexes are solubilized from chromatin and immunopre-
cipitated (Churchman and Weissman, 2011). Analysis of en-
riched factors was consistent with previous Pol II proteomics
studies and in identifying many known transcription and RNA-
processing factors (Figure S1A) (Mosley et al., 2011, 2013; Tar-
diff et al., 2007).
In order to investigate direct and indirect Pol II interactors
specific to each CTD phosphoisoform, we developed a native
sequential immunoprecipitation (IP) strategy to purify Pol II com-
plexes enriched for different phosphorylated CTD residues (Fig-
ure 1A). Our strategy is designed to purify the host of proteins
that interact both directly and indirectly with Pol II when a partic-
ular residue is phosphorylated. Thus, we obtain a comprehen-
sive picture of the co-occurring processes marked by each
phosphorylated residue. To this end, all Pol II complexes are first
purified via a 33 FLAG epitope tag to isolate the full complement
of Pol II phosphoisoforms (five phosphorylatable residues across
26 repeats). From this pool, highly efficient IPs enrich for sets of
phosphoisoforms with well-characterized and specific antisera
targeting each phosphorylatable residue (Tyr1P, Ser2P, Ser5P,
Thr4P, andSer7P) or with amock antisera (mCherry) (Figure S1B)
(Hintermair et al., 2012; Mayer et al., 2012). Native IP conditions
were chosen instead of crosslinking in order to reduce the pos-
sibility for false positives. Importantly, the repetitive nature of the
CTD permits the purification of factors that directly bind the tar-
geted phospho-CTD residue even in the case that their associa-
tion is displaced by the antibody interaction. Nevertheless, for
direct interactors, our purification strategy has the potential
to be less quantitative and may yield false negatives. Each
phospho-specific IP purifies a subset of Pol II complexes that
are highly enriched for the selected phosphorylated residue,
yet are also phosphorylated on other residues across the 26
repeats, thus allowing for the enrichment of indirectly associ-
ating factors recruited by frequently co-occurring patterns of
Pol II modifications (Figure S1C). Furthermore, our strategy will
isolate any proteins that are bound to the nascent RNA. In
sum, this approach comprehensively purifies proteins that
interact directly and indirectly with Pol II coincident with each
phosphorylation mark.
To identify enriched factors in a quantitative manner, samples
from the Pol II IP, each phospho-specific IP, and the mock IP
were analyzed by mass spectrometry in biological triplicate.
Significantly enriched factors in each phospho-specific IP were
determined using quantitative label-free proteomic analysis
(Hubner and Mann, 2011; Hubner et al., 2010). Specifically, the
phospho-specific:mock IP fold increase of spectral intensities
are compared to p values determined by t tests, generating a vol-
cano plot (Figures 1B, 1C, S1A, and S1D–S1F). Only factors pre-
sent in all three replicates are analyzed and are identified as
significantly enriched using a false discovery rate of 0.05. As
the mock IP is done after the first IP, factors enriched with
each phosphoisoform represent proteins that are enriched
over a background of all Pol II interactors. The stringent nature
of this strategy identifies the most highly enriched factors asso-
ciated with each phosphoisoform. Together, the five Pol II phos-
pho-CTD interactomes contain nearly 200 enriched factors,
including Pol II subunits, RNA-processing factors, transcription
Figure 1. Purification and Analysis of Native
Pol II Complexes
(A) Diagram of native Pol II purification followed by
phospho-specific immunoprecipitations (IPs) and
quantitative label-free mass spectrometry analysis
for each CTD phospho-modification; m7Gppp,
RNA cap.
(B and C) Volcano plots comparing Ser5P (B) and
Ser2P (C) IPs to mock IPs. Specifically enriched
factors determined using an FDR of 0.05 and an S0
value (curve bend, see Supplemental Experi-
mental Procedures for details) of 0.4 for Ser5P and
0.5 for Ser2P are highlighted in black. Factors
mentioned in the text are labeled.
(D) Principal component analysis of significantly
enriched interactors from each phospho-CTD in-
teractome. PC, principal component.
See also Figure S1.factors, and chromatin-related factors. Our analysis successfully
identified factors previously shown to directly associate with
different phospho-CTD isoforms, such as enrichment of the
mRNA capping complex (Cet1 and Ceg1) and the Ser5 kinase
TFIIH in the Ser5P interactome (Figure 1B) (Komarnitsky et al.,
2000; Schroeder et al., 2000) and enrichment of Pcf11 and other
cleavage, polyadenylation, and export factors (Clp1, Rna14, and
Tex1) in the Ser2P interactome (Figure 1C) (Barilla` et al., 2001;
Buratowski, 2005). Although our focus is not entirely on identi-
fying direct phospho-CTD binders, these results demonstrate
that our approach robustly purifies direct Pol II CTD interactors,
presumably facilitated by the repetitive nature of the CTD.
Pol II Phospho-specific Interactomes Are Distinct
Utilizing the stringent nature of the interactome data, we asked
whether the proteins that are highly enriched in each Pol II
CTD interactome constitute distinct groups of factors, which
would suggest that each Pol II phospho-CTD residue connects
to different Pol II regulation modalities and/or co-transcriptional
processes. Principal component analysis of all five phospho-
CTD interactomes demonstrates that each interactome contains
a unique set of factors that are reproducibly identified (Figure 1D)
(Tables S1 and S2). Consistently, we observe minimal overlap of
factors across all interactomes (Figure 2A). Gene ontology (GO)
analysis of all co-purifying factors displays enrichment of many
transcription-related GO terms as well as RNA processing and
chromatin organization (Figure 2B). Additionally, the phospho-
CTD interactomes show enrichment for protein domains
involved in chromatin regulation, RNA processing, and in pro-
moting protein-protein interactions (Figure 2C). Together theseCell Rdata indicate our approach isolates fac-
tors with functions in multiple transcrip-
tional and co-transcriptional processes.
We reasoned that proteins with similar
phospho-CTD interaction profiles should
have related roles in transcription. Pair-
wise correlation analysis between the
phospho-CTD interaction profiles of all
enriched factors followed by hierarchicalclustering identifies distinct groups of factors (Figure 2D). We
find that factors regulating transcription initiation and early
transcriptional processes, such as mRNA capping, are highly
correlated and are anti-correlated with factors enriched for
30 end processing of nascent RNA. Also, a majority of transcrip-
tion elongation factors cluster together, revealing that proteins
associated with the three major stages of transcription interact
with Pol II in distinct modes with specific phospho-CTD states.
These data demonstrate that the interactome of a phospho-
CTD residue can be used to predict its function in transcription.
CTD Thr4 and Rtt103 Transition Pol II to Termination
As many functions have been attributed to the well-character-
ized CTD phosphoisoforms, Ser5P and Ser2P, we utilized the
phospho-CTD interactome dataset to explore the lesser-studied
Thr4P phosphoisoform. Moreover, mass spectrometry analysis
of the Pol II CTD demonstrated that Thr4P is a prevalent modifi-
cation, possibly as abundant as Ser2P (Sch€uller et al., 2016; Suh
et al., 2016). Purification of Pol II CTD Thr4P complexes was
reproducibly efficient (95% average IP efficiency, Figure S1B),
and mass spectrometry analysis revealed significant associa-
tions between Thr4P and a number of canonical transcription
elongation factors (Figure 3A). Interestingly, the transcription
termination factor Rtt103 was also enriched with Thr4P. Rtt103
is a CTD binding protein that functions with the exonuclease
complex Rat1/Rai1 for termination of polyadenylated transcripts
(Buratowski, 2005; Kim et al., 2004) and was recently demon-
strated to interact with a CTD containing phosphorylated Thr4
(Suh et al., 2016). To decipher whether interaction of Rtt103
with Pol II complexes is a direct result of Thr4 phosphorylation,eports 15, 2147–2158, June 7, 2016 2149
Figure 2. Pol II Phospho-CTD Interactomes Contain Unique Sets of Factors
(A) Venn diagram of enriched factors from the interactome of each CTD phosphoisoform.
(B) Gene ontology terms enriched in the phospho-CTD interactome data are plotted for each phosphoisoform.
(C) Protein domains enriched in the phospho-CTD interactomes. The abundance of the top 12 protein domains identified in the phospho-CTD interactome
compared to their abundance in the yeast proteome. Fisher exact test, *p < 0.05, **p < 0.01. LC, low complexity; HAT, half-A-TPR repeat; WD40, repeat ending in
tryptophan-aspatic acid repeat; RRM, RNA recognition motif; TPR, tetratricopeptide repeat; DEAXD, DEAD-like helicase; AAA, ATPases; HELIC, helicases; CBS,
cystathionine beta synthase domain; BRCT, breast cancer c-terminal; CHROMO, chromatin organization modifier; WW, two conversed Trp resides.
(D) Clustered pairwise correlation matrix comparing phospho-CTD interaction profiles of all enriched factors. GO terms enriched in separate clusters, p values for
the significance of enrichment of each GO term, and representative factors in each cluster are indicated.we tested the ability of the Thr4P antisera to competewith Rtt103
for CTD binding. After purifying Pol II complexes using a FLAG
epitope tag on the Rpb3 subunit, antisera directed against
Thr4P, Ser2P, Ser5P, no antisera, or FLAG peptide (as a positive
elution control) was incubated in vast excess (>13-fold higher
concentration compared to the IP reactions) with the purified
complexes on beads. Supernatant and bead fractions were
assayed by western blot (Figure 3B). As expected, the Ser2P
antisera were able to compete with Rtt103 for CTD binding
(Kim et al., 2004), and the Ser5P antisera were not effective
competition. Consistent with the mass spectrometry data,
Thr4P antisera were also able to compete with Rtt103 for CTD
binding, indicating both residues likely regulate the interaction
between Rtt103 and the Pol II CTD.
Surprisingly, the Rat1/Rai1 exonuclease complex was not en-
riched in the Thr4P interactome, leading us to postulate that
Rtt103 and Rat1/Rai1 may regulate separate steps in the termi-
nation process. To test this hypothesis, we used NET-seq, which
maps actively transcribing Pol II complexes at nucleotide resolu-
tion genome-wide (Churchman and Weissman, 2011) and
analyzed changes in Pol II density in rtt103D and rai1D deletion
mutants after polyA sites. Aggregate analysis of wild-type2150 Cell Reports 15, 2147–2158, June 7, 2016NET-seq data around polyA sites reveals an increase in Pol II
density just after polyA sites where 30 end cleavage occurs co-
transcriptionally (Figure 3C, black line). Subsequent termination
leads to a decrease in Pol II density before neighboring genes in-
crease the signal again. Individual deletion of RAI1 and RTT103
caused widespread termination defects, albeit in very different
ways (Figures 3C and S2A). Loss of RAI1 (Figure 3C, green
line) leads to a steady rise in Pol II density after polyA sites, indi-
cating that transcription proceeds for much longer. In contrast,
loss of RTT103 (Figures 3C and 3D, blue line) results in a pro-
nounced peak of Pol II density directly after polyA sites precisely
where Rtt103 occupancy peaks (Figure S2B) (Mayer et al., 2012).
Furthermore, termination is not affected as Pol II density de-
creases normally thereafter, suggesting that instead Rtt103
binding regulates the onset of termination.
As Rtt103 is enriched in the Thr4P interactome, we postulated
that Thr4 aids Rtt103 in regulating Pol II. We mapped Thr4P
genome-wide at near nucleotide resolution using exonuclease-
based chromatin immunoprecipitation (ChIP)-nexus (He et al.,
2015), which revealed a peak of threonine-4 phosphorylation
downstream of the polyA site, where the peak in Pol II density
is observed in the rtt103D strain (Figure 3D purple line, and
Figure 3. Thr4P Regulates Pol II Dynamics
during Transcription Termination
(A) Volcano plot comparing Thr4P IPs to mock IPs.
Specifically enriched factors are determined using
an FDR of 0.05 and S0 = 0.5 and are highlighted in
black. Factors mentioned in the text are labeled;
Rtt103 is labeled in blue.
(B) Western blot (top) and quantification (bottom)
of the amount of Rtt103 or Rpb3 eluted from pu-
rified Pol II complexes by phospho-CTD antisera
(no Ab, Ser5P, Ser2P, Thr4P) or FLAG peptide.
Competition assays were conducted in biological
triplicate. Plotted are mean fraction eluted values;
error bars, SD. NS, not significant; *p < 0.01; Ab,
antibody; B, beads; S, supernatant.
(C) Normalized average NET-seq profiles of WT,
rtt103D, and rai1D cells at polyadenylation sites
(polyA) of protein coding genes.
(D) Normalized average NET-seq profiles of
rtt103D and T4V1–26 mutant CTD cells and
normalized average ChIP-nexus profile of Thr4P at
the polyA site of protein coding genes. In (C) and
(D), NET-seq and ChIP-nexus reads for each gene
are normalized by total reads for each gene in the
analyzed region; shaded areas represent the 95%
confidence interval. n = 2,738. A.U., arbitrary units.
See also Figures S2 and S3.Figures S2B and S2D–S2G). Consistent with our detection of
Rtt103 in the Thr4P interactome, the peak in Thr4P density over-
lapswith Rtt103 density (Figure S2B). To determinewhether Thr4
controls 30 end cleavage and transcription termination, we
replaced each Thr4 residue in the endogenous 26 CTD hepta-
peptide repeats with a valine residue (T4V1–26), representing a
non-phosphorylatable state, and with a glutamic acid residue
(T4E1–26), mimicking the constitutively phosphorylated state.
The T4E1–26 mutant is lethal (Figure S3A), but the T4V1–26 mutant
is viable, as observed previously (Rosonina et al., 2014), with a
modest growth defect (15% increase in doubling time). NET-
seq analysis at the 30 ends of genes demonstrates that the
T4V1–26 strain has a similar post-polyA transcription defect as
the rtt103D strain with a strong increase in Pol II density after
polyA sites, at exactly the location where Thr4P peaks in occu-
pancy (Figures 3D and S2A, red line). A less stringent and induc-
ible T4Vmutant was created by generating an allele of RPB1 that
encodes a CTD where Thr4 of the first eight repeats proximal to
the Pol II core are mutated to valine (T4V1–8). By placing the
endogenous RPB1 under control of a Tet-off promoter, introduc-
tion of doxycycline induces incorporation of the mutant CTD into
the Pol II complex (Malagon et al., 2006;Morrill et al., 2016). NET-
seq analysis in this T4V1–8 mutant shows defects similar to the
T4V1–26 mutant in post-polyA transcription (Figure S3B). RNA
sequencing (RNA-seq) analysis of the T4V1–26 strain shows a
global downstream shift in the locations of polyA sites, consis-
tent with a possibility of altered cleavage in this strain (Figures
S3C–S3E). Importantly, no downregulation of transcription elon-
gation or RNA-processing-related gene classes was detected ineither the T4V1–26 or rtt103Dmutants (Table S3; Figures S2C and
S6E). Together these data lead to a model by which both Ser2P
and Thr4P recruit Rtt103 after polyA sites and indicate the pres-
ence of a post-polyA checkpoint controlled by Thr4 that ensures
robust 30 end cleavage followed by an efficient transition to tran-
scription termination. Moreover, these data illustrate how anal-
ysis of Pol II CTD interactomes reveals distinct roles for CTD
modifications and their interacting factors.
CTD Ser5P Is Enriched for Spliceosomal Components
while Thr4P Is Depleted
To search for additional connections between Thr4P and
RNA-processing events, we compared the interactomes by
complete-linkage hierarchical clustering. Interestingly, CTD
phosphorylation marks with similar ChIP occupancy (Ser5P/
Ser7P and Tyr1P/Ser2P) have interactomes that cluster together
(Figure 4A), and the Thr4P interactome does not cluster with any
other phospho-CTD interactome. A major feature separating the
Thr4P interactome is the absence of enriched spliceosomal sub-
units (Figure 4B) while other phospho-CTD interactomes enrich
for eight to 18 spliceosomal subunits across five subcomplexes.
In contrast, the Ser5P interactome is highly enriched for many
components of the U1 spliceosomal complex, purifying nearly
70% of U1-associated proteins. To determine whether U1 is
associating through a protein-protein interaction with Ser5P,
we tested the ability of Ser5P antisera to displace U1 from puri-
fied Pol II complexes. Ser5P antisera were able to elute nearly
half of the associated U1 from the CTD, while Thr4P antisera
were unable to significantly compete with U1 binding (Figure 4C).Cell Reports 15, 2147–2158, June 7, 2016 2151
Figure 4. Phospho-CTD Interactomes Reveal Connection between Pol II CTD Ser5P, Thr4P, and Splicing
(A) Complete linkage clustering of each Pol II phospho-CTD interactome.
(B) Heatmap of splicing factors specifically enriched in each phospho-CTD Pol II interactome.
(C) Western blot (top) and quantification (bottom) of the amount of Mud1 (U1) or Rpb3 eluted from purified Pol II complexes by phospho-CTD antisera (no Ab,
Ser5P, Thr4P) or FLAG peptide. Competition assays were conducted in biological triplicate. Plotted are mean fraction eluted values, error bars, SD; NS, not
significant; *p < 0.05; Ab, antibody; B, beads; S, supernatant.These data suggest that U1 directly associates with Pol II in a
Ser5P-dependent manner. The difference in enrichment and
interaction with the spliceosome between Ser5P and Thr4P sug-
gest each phospho-modificationmay regulate different stages of
splicing.
Co-transcriptional Spliceosome Recruitment Is
Facilitated by Ser5P
To examine the roles of both Ser5P and Thr4P in coordinating
splicing, we first analyzed the co-transcriptional recruitment of
the spliceosome through mapping obligatory components of
the U1 and U2 spliceosomal subcomplexes, Mud1 and Lea1,
respectively. Analysis of U1 and U2 occupancy by ChIP-nexus
displays enrichment for spliced genes and matches lower-reso-
lution profiles around the 30 splice site fromU1 and U2 ChIP-chip
data (Tardiff et al., 2006) (Figures S4A–S4E). We observe high
levels of U1 and U2 enrichment over spliced genes, and, consis-
tent with other studies, we observe low signal over unspliced
genes (Figure S4D) (Kotovic et al., 2003; Moore et al., 2006; Tar-
diff et al., 2006). Hierarchical clustering of the data based on U1
occupancy breaks spliceosome occupancy into two clear cate-
gories of high- and low-occupancy genes, which had been
observed previously (Figure 5A; Table S4) (Tardiff et al., 2006).
The high-occupancy genes tend to be highly co-transcriptionally
spliced and well expressed, to have longer introns and shorter
terminal exons, and to encode ribosomal proteins (Figure S4F)
(Carrillo Oesterreich et al., 2010). We focused our analysis on
the high-occupancy genes. The ChIP-nexus data resolve a rapid
and sharp increase in U1 occupancy 10–30 bp downstream of
the 30 splice site that remains high for 200 bp before decreasing
(Figures 5B and 5C). Extending for almost 400 bp, U2 occupancy
also increases sharply at the 30 splice site, albeit more slowly2152 Cell Reports 15, 2147–2158, June 7, 2016than U1, consistent with ordered spliceosomal assembly (Fig-
ures 5C and S4G) (Hoskins et al., 2011).
From our Pol II CTD interactomes, we postulated that Ser5P
occupancy would mirror U1. ChIP-nexus analysis of Ser5P
occupancy revealed a characteristic peak of enrichment near
transcription start sites of coding genes (Figures S5A–S5C).
Interestingly, analysis around 30 splice sites of high U1 occu-
pancy genes displays a sharp increase in Ser5P 10–30 bp down-
stream of the 30 splice site that persists for 200 bp, overlaying
precisely with the U1 peak (Figures 5B and 5C). In contrast,
Thr4P peaks late into the terminal exon, concomitant with low
levels of Ser5P, U1, and U2 (Figures 5B and 5C). Interestingly,
the peak of Thr4P in the terminal exon occurs just prior to polyA
sites and is distinct from the peak of Thr4P after polyA sites (Fig-
ures 5B, 5C, and S5D). The bimodal Thr4P profile around the
polyA sites is not observed at unspliced genes where only a sin-
gle peak occurs after polyA sites (Figure S2G). These trends can
be observed through comparison of raw ChIP-nexus signal be-
tween U1 and Ser5P (Pearson correlation, r = 0.61) or Thr4P
(Pearson correlation, r = 0.02) across terminal exons (Figures
5D and S5F). These data suggest that Ser5P recruits the spliceo-
some at the 30 splice site and that when the spliceosome disso-
ciates, high levels of Thr4P are present. Importantly, U1 and U2
occupancy profiles are not altered in the T4V1–26 mutant (Fig-
ure S5E), suggesting that Thr4 does not cause the dissociation
of the spliceosome, and that instead high levels of Thr4P act
as a mark of spliceosome release.
The increase in Ser5P and rapid recruitment of U1 at the
30 splice site are coincident with a previously proposed splicing
checkpoint involving Ser5P and Pol II pausing around the
30 splice site (Alexander et al., 2010; Chathoth et al., 2014).
Furthermore, pausing has been observed elsewhere at spliced
Figure 5. Pol II CTD Ser5P and Thr4P Regulate Spliceosome Occupancy and Splicing Dynamics
(A) Heatmap of normalized U1 (Mud1) and U2 (Lea1) ChIP occupancies around the 30 splice site (300 bp upstream and 1,000 bp downstream) of non-overlapping
intron-containing genes (see Supplemental Experimental Procedures). Genes are classified as high (High Occ.) or low occupancy (Low Occ.) based on U1
recruitment.
(B) Heatmap of normalized Ser5P, U1, and Thr4P ChIP occupancies around the 30 splice site (300 bp upstream and 1,000 bp downstream) of high U1 occupancy
genes. Dashed lines represent the 30 splice site and polyadenylation site, respectively.
(C) Left: normalized average ChIP-nexus profiles of U1 (Mud1) and U2 (Lea1) around the 30 splice site (30SS) of high U1 occupancy spliced genes. Normalization of
ChIP data to internal spike-ins allows direct comparison of U1 and U2 profiles. Right: normalized average ChIP-nexus profiles of Ser5P and Thr4P and U1 around
the 30 splice site of high U1 occupancy spliced genes. n = 109, Shaded areas represent 95% confidence intervals.
(D) Comparison of U1 (Mud1) and Ser5P (green) or U1 and Thr4P (purple) ChIP-nexus reads from the 30 splice site to 100 bp past the polyA site of high U1
occupancy spliced genes (n = 109). R, Pearson correlation coefficient.
In (A)–(C), ChIP-nexus reads for each gene are normalized by total reads for each gene in the analyzed region.
See also Figures S4 and S5.genes in yeast (Carrillo Oesterreich et al., 2010). However, these
studies have been limited by low resolution or indirect methods
to detect transcriptional pausing. We analyzed NET-seq profiles
of high-occupancy genes around the 30 splice site (30 SS) in an
effort to resolve putative splicing checkpoints at nucleotide res-
olution. Analysis by NET-seq revealed highly reproducible pat-
terns of Pol II pausing at intron-exon junctions as well as
increased Pol II density over exons similar to earlier observations
in yeast and in human cells (Figures 6A, 6B, and S5G) (Alexander
et al., 2010; Jonkers et al., 2014; Mayer et al., 2015; Veloso et al.,
2014). Splicing intermediates, such as lariats, are known con-
taminants in NET-seq data, so the precise nucleotide position
where their 30 ends align are removed from analysis, resulting
in a single nucleotide gap. In order to determine whether the re-
maining signal upstream and downstream of the 30 SS are due tolariats frommissplicing events, we sequenced total nascent RNA
in order to analyze the abundance of alternative splicing junc-
tions. Greater than 99% of transcripts are correctly spliced (Fig-
ure S5H), strongly indicating that the NET-seq signal around the
30 SS is due to Pol II pausing. Moreover, pausing at the 30 SS is
observed uniformly across spliced genes with high U1 recruit-
ment (Figure 6A). Together these data suggest coordination be-
tween Pol II dynamics, Ser5 phosphorylation, and recruitment of
the spliceosome during a splicing checkpoint at the 30 splice site.
We reasoned that if Ser5P is responsible for the rapid and pre-
cise recruitment of U1 directly following 30 splice sites, then a
loss of Ser5 would disrupt splicing. As complete loss of Ser5 is
lethal, we created an allele of the RPB1 gene that encodes the
CTD where Ser5 of the first eight repeats proximal to the Pol II
core are mutated to alanine (S5A1–8), similar to the T4V1–8 strain.Cell Reports 15, 2147–2158, June 7, 2016 2153
Figure 6. Pol II CTD Thr4 Regulates Post-transcriptional Splicing
(A) Heatmap of normalized NET-seq reads around the 30 splice site of high U1 occupancy genes.
(B) Normalized average NET-seq reads of around the 30 splice site of high U1 occupancy genes. NET-seq reads for each gene are normalized by total reads for
each gene in the analyzed region. Shaded areas represent 95% confidence intervals. Splicing intermediates are contaminants in NET-seq data, so the precise
1-bp positions where they align are removed from analysis and lead to a gap in the Pol II density profiles. A.U., arbitrarty units, n = 109.
(C) Quantification of themean difference in unspliced versus spliced transcripts inWT and T4V1–26 CTDmutant cells as determined by qPCR of splice junctions at
five spliced genes. Error bars, SD of three biological replicates. *p < 0.05, **p < 0.01. Top: diagram depicting primer pairs used to determine spliced (black forward
arrow) and unspliced (red forward arrow) transcript abundance.
(legend continued on next page)
2154 Cell Reports 15, 2147–2158, June 7, 2016
We also constructed similar alleles for Ser2 (S2A1–8) and for Ser7
(S7A1–8). Here, the endogenous RPB1 is again controlled by a
Tet-off promoter, and we investigated the splicing phenotype
in total RNA of these strains as well as the T4V1–8 strain after
exposing the cells to doxycycline. Real-time qPCR analysis
of splice junctions revealed that, in contrast to S2A1–8 and
S7A1–8, both S5A1–8 and T4V1–8 lead to intron retention at the
RPL34B gene (Figure S6A), demonstrating the functional impor-
tance of Ser5P for efficient splicing, presumably through the
recruitment of U1.
Thr4 Is Responsible for Efficient Post-transcriptional
Splicing Genome-wide
The pre-polyA peak of Thr4P specifically at spliced genes, a lack
of enriched spliceosomal subunits in the Thr4P interactome, and
the splicing defect observed in the T4V1–8 strain lead us to postu-
late that Thr4 has a role in splicing. The splicing defect caused by
the T4V1–8 mutation is likely to be a modest phenotype as there
are still 18 wild-type repeats. Indeed, real-time qPCR analysis of
the T4V1–26 strain revealed a much stronger splicing defect at
five genes (Figure 6C). To ask whether the splicing defect arises
co-transcriptionally, we generated nascent RNA-seq data for
wild-type (WT) and T4V1–26 cells. Using two different metrics,
we show that 73% of transcripts are co-transcriptionally spliced,
consistent with previous reports, with no difference between WT
and T4V1–26 cells (Carrillo Oesterreich et al., 2010) (Figure 6D).
Consistently, we observe no defect in the co-transcriptional
recruitment of U1 or U2 in the T4V1–26 strain (Figure S5E). We
next considered whether post-transcriptional splicing is globally
impacted by a replacement of Thr4 with valine by performing
total RNA-seq. The inclusion of RNA standards allowed for an
accurate and quantitative measure of intron retention genome-
wide (Figures S6B–S6E). Comparison of T4V1–26 and wild-type
strains reveal 90% of spliced genes have increased intron reten-
tion in the T4V1–26 strain and that 38% display a greater than
2-fold increase (Figures 6E and S6F–S6H). Importantly, no
downregulation of transcription elongation, splicing, RNA pro-
cessing, or RNA-turnover-related gene classes was detected
(Table S3). Furthermore, a re-analysis of RNA-seq data from a
T4V mutant reported in Rosonina et al. also reveals a splicing
defect (Rosonina et al., 2014) (Figure S6I). Thus, Thr4 does not
impact co-transcriptional splicing and is instead a critical residue
for ensuring efficient splicing post-transcriptionally.
DISCUSSION
Transcription elongation proceeds through multiple stages,
marked by distinct CTD phosphorylation patterns and by the(D) Mean fraction of co-transcriptionally spliced transcripts as determined by na
cupancy genes. Twometricswere used to determine co-transcriptionally spliced r
the number of spliced reads by the total number of reads (spliced + unspliced) spa
to exon coverage in a region spanning 25 bp up- or downstream of the 30 splice site
and 30 splice site metrics. Error bars, SD.
(E) Distribution of the increase in intron retention in the T4V1–26 CTDmutant versus
in the analysis contained reliably quantifiable intron coverage as determined by
Procedures).
See also Figures S5 and S6.set of factors regulating Pol II to coordinate co-transcriptional
processes. Here, we combined phospho-specific CTD Pol II pu-
rification with quantitative mass spectrometry to identify the in-
teractomes of each phospho-CTD residue. Importantly, we
observe minimal overlap of factors across phospho-CTD inter-
actomes, emphasizing the unique roles of each phosphorylation
mark. The interactomes reveal the complement of factors inter-
acting with Pol II throughout transcription elongation and will
serve as a resource for future studies on the regulation of tran-
scription and co-transcriptional processes.
The Ser5P and Ser2P modifications have been studied exten-
sively, but recent studies have demonstrated that all the phos-
pho-modifications of the CTD can regulate the transcription
process (Descostes et al., 2014; Egloff et al., 2007; Hintermair
et al., 2012; Hsin et al., 2011, 2014a, 2014b; Mayer et al.,
2012; Rosonina et al., 2014). Furthermore, our work and that of
others suggest that factors interact with Pol II in a highly regu-
lated manner requiring multiple inputs (presence or absence of
particular CTD phosphorylation marks, cis-acting elements in
the nascent RNA, etc.) (Kim et al., 2004; Komarnitsky et al.,
2000; Lacadie and Rosbash, 2005; Lacadie et al., 2006; Licata-
losi et al., 2002;McCracken et al., 1997;Mayer et al., 2010, 2012;
Moore et al., 2006; Schwer and Shuman 2011; Suh et al., 2016).
For example, Ser2P and the lack of Tyr1P are proposed to facil-
itate the localization of Rtt103 to Pol II (Mayer et al., 2012). Here,
we describe Thr4P as an additional input to this process. Our
data are consistent with a model whereby Thr4 phosphorylation
aids the recruitment of Rtt103 to the transcription elongation
complex, followed by a Rtt103/Thr4-regulated release of Pol II
from a region of pausing after polyA sites (Figure 7). These results
raise the possibility that Pol II slows transcription until the arrival
of Rtt103 and the onset of termination. Thus, Thr4 joins Tyr1
and Ser2 in facilitating the precise and timely association of
Rtt103 with the transcription elongation complex, indicating
that the ‘‘CTD code’’ includes intricate CTD phosphorylation
combinations to orchestrate the connections between transcrip-
tion and co-transcriptional processes. Interestingly, the recruit-
ment of Rtt103 may be even more complicated as we also
observe a strong enrichment for Rtt103 with Pol II CTD Ser7P
(Table S1).
Our data reveal that the coupling of transcription to splicing is
also controlled by multiple inputs, revealing CTD Ser5 and Thr4
as being critical links between transcription and splicing. Our
analyses suggest a model in which after Pol II releases from a
30 splice site pause, the U1 spliceosomal subcomplex is rapidly
recruited to Pol II through physical interaction with Ser5P. U2
subsequently associates, which presumably leads to co-tran-
scriptional splicing (Figure 7). Interestingly, Mud1 (U1) does notscent RNA-seq in WT (black) or the T4V1–26 CTD mutant (red) in high U1 oc-
eads: fraction spliced, which calculates the fraction of spliced reads by dividing
nning the 30 splice site and 30 splice site coverage, which uses the ratio of intron
and subtracting this value from 1. Top: diagrams depicting the fraction spliced
WT cells for two biological replicates (n = 107 and 108 genes). Genes included
RNA standards in both samples (Figure S6B and Supplemental Experimental
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Figure 7. Coupling of Transcription to RNA Processing by Ser5P and Thr4P
Model displaying how Ser5 and Thr4 phosphorylation coordinates the pausing of Pol II the at the 30 splice site (1), recruitment of the splicing machinery (2),
completion of splicing and release of the spliceosome (3), pausing for 30 end processing and recruitment of Rtt103 (4), and the transition from 30 end processing to
termination (5).co-localize with the canonical Ser5P peak at the 50 end of all
genes, indicating that Ser5P is not sufficient for U1 recruitment.
Certainly known interactions between U1 and the nascent RNA
likely serve as additional inputs to ensure proper localization
(Lacadie and Rosbash, 2005). After 30 splice sites, Thr4P levels
increase steadily and peak after U1 and U2. These occupancy
data and the lack of spliceosomal subunits in the Thr4P inter-
actome suggest that high levels of Thr4P mark spliceosomal
release. Interestingly, we observe that Thr4 is strongly con-
nected to post-transcriptional splicing, but how is thismediated?
A modest peak of spliceosome recruitment occurs after polyA
sites where both U1 and U2 are simultaneously re-recruited (Fig-
ure S5D). As links between splicing, 30 end processing and termi-
nation have been described (Albulescu et al., 2012;Martins et al.,
2011) an intriguing possibility is that Thr4 coordinates the
commitment to post-transcriptional splicing during 30 end pro-
cessing and termination. In sum, the phospho-specific Pol II
interactomes transform our understanding of critical co-tran-
scriptional gene regulatory mechanisms through disentangling
the complex interactions of CTD phosphorylation and regulatory
factors.EXPERIMENTAL PROCEDURES
CTD Immunoprecipitation
Yeast cultures grown to mid-log phase in YPD were flash frozen in liquid
nitrogen and pulverized by a ball-bearing mixer mill (Retsch MM400). 1 g of
grindate was resuspended in 5 ml of 1 3 lysis buffer (20 mM HEPES
[pH 7.4], 110 mM KOAc, 0.5 Triton X-100, 0.1% Tween 20, 10 mM MnCl2,
8 U ml–1 RNasin [Promega], 13 cOmplete EDTA free protease inhibitor cock-
tail [Roche], and 13 PhosSTOP [Roche]). 660 U of RQ1 DNase (Promega) was
added, and the lysate was incubated for 20 min on ice and centrifuged at
20,000 3 g for 10 min at 4C. Supernatant was added to 500 ml of anti-
FLAG M2 affinity gel (Sigma-Aldrich) and rotated at 4C for 1 hr. IPs were
washed three times for 5 min at 4C with 10 ml of 1 3 wash buffer (20 mM
HEPES [pH 7.4], 110 mM KOAc, 0.5 Triton X-100, 0.1% Tween 20, 8 U ml–1
RNasin, 1mMEDTA) and eluted (two times) in 300 ml of 2mg/ml 33 FLAGpep-
tide (Sigma-Aldrich). Elutions were combined, and 100 ml of eluate was used
for mass spectrometry analysis. For phospho-CTD IPs, 250 ml of the combined
elution was added to magnetic beads covalently coupled to 33 mg of phospho-
specific CTD antibodies (Active Motif; Ser5P, 3E8 [61085]; Ser7P, 4E12
[61087]; Ser2P, 3E10 [61083]; Tyr1P, 3D12 [61383]; Thr4P, 6D7 [61361]) or
33 mg of mCherry rat monoclonal antibody (Life Technologies, M11217) for
mock IPs and incubated at 4C for 30 min. Samples were then washed three2156 Cell Reports 15, 2147–2158, June 7, 2016times by pipetting and one time by rotating for 5 min in 1 ml of wash buffer
at 4C and eluted using 0.1 M Gly (pH 2).
NET-Seq and Nascent RNA-Seq
NET-seq growth conditions, IPs, and isolation of nascent RNA and library con-
struction were carried out as described in Churchman and Weissman (2012).
NET-seq linker ligation was done directly to the 30 end of isolated nascent
RNA. For nascent RNA-seq, the RNA was fragmented followed by dephos-
phorylation and linker ligation. Libraries were then subjected to 30 end
sequencing.
RNA-Seq
Total RNA from mid-log yeast cultures was harvested using standard hot
phenol-chloroform extraction methods. ERCC RNA standard mix 1 (Life Tech-
nologies) was added and rRNA was depleted using the Ribo-Zero Gold rRNA
removal kit for yeast (Illumina). Library generation was carried out according to
the procedure in Churchman and Weissman (2012) followed by 30 end
sequencing.
ChIP-Nexus
Methods to adapt ChIP-nexus to yeast were obtained through personal
communication from Stephen Doris and Fred Winston and will be published
elsewhere. Library generation was carried out as described in He et al. (2015).
Mass Spectrometry Analysis
Trichloroacetic acid (TCA) precipitated samples were separated on 12%acryl-
amide gels, extracted, and submitted to the Taplin Mass Spectrometry Facility
at Harvard Medical School for analysis. All mass spectrometry data analysis
was done using the Perseus software (Hubner and Mann, 2011; Hubner
et al., 2010). Summed MS1 intensities for the triplicate IPs were loaded into
Perseus along with the respective mock control dataset. Datasets were log2
transformed and filtered for proteins present in all three specific or mock
IPs. Missing values were imputed, and data were normalized by median
subtraction. Enriched proteins were defined using a false discovery rate
(FDR) of 0.05.
Processing and Alignment of Sequencing Data
NET-seq and RNA-seq reads were trimmed and aligned using TopHat2 and
library generation artifacts removed. For NET-seq, the 50 end of the
sequencing, which corresponds to the 30 end of the nascent RNA fragment,
is recorded with a custom Python script using HTSeq package. For RNA-
seq and nascent RNA-seq the same script was used, this time recording the
entire read. NET-seq and nascent RNA-seq data are normalized by million
mapped reads. Positions of splicing intermediates in NET-seq data are
removed from analysis. ChIP-nexus reads are selected for the fixed barcode,
trimmed, and aligned using Bowtie. Plus and minus strand coverage are com-
bined and the 50 end of the sequencing read is recorded and normalized by the
spike-in, corresponding to the number of mapped S. pombe reads.
Gene Expression and Intron Retention Analysis
All RNA-seq reads were normalized using ERCC RNA standards mix 1 (Life
Technologies) by the number of 104 uniquely mapping ERCC reads. For
gene expression analysis the reads per gene were calculated for genes that
were expressed in at least one replicate in either the WT or T4V strains. For
intron retention analysis, the normalized reads per length in Kb (RPK) was
calculated for each intron and exon in non-overlapping spliced genes as
well as spliced genes where overlap did not occur on the same strand. To
determine which RPK values could be reliably quantified, the concentration
of ERCC standards was plotted against the RPK scores for the ERCC stan-
dards in each library (Figure S5A). For intron retention analysis, only those
genes with intron and exon RPK values greater than 75 in both WT and T4V
samples were analyzed.
Metagene Analysis
NET-seq and ChIP-nexus reads from wild-type or mutant strains were scored
around the TSS, polyA, and the 30 splice sites of non-overlapping genes in 1-bp
bins using the deepTools program. The TSS and polyA average profiles were
calculated using a sliding window of 25 bp for non-overlapping protein coding
genes with a Reads per kilobase per million maped reads (RPKM) >10 in the
WT NET-seq data and are at least 500 bp long. For average profiles around
the 30 splice site, high-occupancy non-overlapping spliced genes as well as
spliced genes where overlap did not occur on the same strand were analyzed.
Real-Time qPCR
Yeast was cultured and RNA extracted as described in RNA-seqmethods. For
CTD1–8 mutants cells were grown in SC-leu media containing 2% glucose and
50 mg/ml doxycycline (Clontech Laboratories). Total RNA was harvested using
standard hot phenol-chloroform extractionmethods, ethanol precipitated, and
DNase treated using RQ1 DNase (Promega). cDNA was then generated from
gene-specific RT primers using SuperScript III (Life Sciences). qPCR was
done using SsoFast Supermix (BioRad) and carried out on a Bio-Rad
CFX384 Real-Time System with a C1000 Theromycylcer.
Antibody Competition Assay
Pol II was immunopurified as described above. Samples were split into five
aliquots of 200 ml each. To each sample, 100 ml of wash buffer containing 0
or 20 mg of phospho-CTD antibody or 100 ml of 2 mg/ml FLAG peptide was
added. Samples were incubated for 30 min at 4C followed by centrifugation
to collect the beads. The beads (B) and supernatant (S) fractions were then
analyzed by western blot.
Statistical Methods
p values for mass spectrometry analysis, antibody competition assays, and
qPCR data were calculated using two-sample, two-tailed t tests. FDRs in vol-
cano plot analysis were calculated using a permutation-based FDR for each
dataset. p value in Figure S3E was calculated using a paired two-sample
t test. p values for GO term enrichment were obtained from GO term finder
at theSaccharomycesGenomeDatabase website. p values comparing protein
domain enrichment were calculated using Fisher’s exact test.
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